|
Dietary supplement (DS)/food | Dietary products | Study type | Subject/model (number) | Study design | Outcome measures | Effect | Mechanism | References |
|
Food | Alcohol | Animal | Male CD-1 mice (10 in each group) | Randomized parallel design | PD parameters | Additive neurotoxicity (ethanol-induced motor incoordination and loss of righting reflex potentiated ) | Nonadenosinergic action | Dar et al. 1989 [54] |
|
Food | Alcohol | Human | Healthy volunteers (8) | Open label crossover study | PK parameters | No effect on pharmacokinetics of CBZ | Low ethanol level in subjects |
Sternebring et al. 1992 [55] |
|
Food | Alcohol | Human | Alcoholics (7) | Open label crossover study | PK parameters | Increased AU of CBZ and decreased AU of CBZ 10,11-epoxide | Acute inhibition of CBZ metabolism and/or accelerated CBZ metabolism in abstinence phase due to enzyme induction by previous ethanol abuse |
Sternebring et al. 1992 [55] |
|
Food | Butter | Animal | New Zealand white rabbit (8 in each group) | Crossover study | PK parameters | Increased bioavailability of CBZ | Improved solubility and dissolution of poorly soluble CBZ | Sidhu et al. 2004 [56] |
|
Food | Caffeine | Human | Healthy male volunteers (6) | Open label crossover study | PK parameters | Decreased bioavailability and increased of CBZ | Involving metabolism by mixed function oxidase | Vaz et al. 1998 [57] |
|
Food | Caffeine | Animal | Albino Swiss male mice with maximal electroshock seizure model (7 in each group) | Randomized controlled parallel study | PK and PD parameters | Acute caffeine decreased antiepileptic efficacy of CBZ but had no effect on plasma level of CBZ | N.D. | Czuczwar et al. 1990 [58] |
|
Food | Caffeine | Animal | Swiss male mice with maximal electroshock seizure model (8 in each group) | Randomized controlled study | PK and PD parameters | Chronic caffeine dose-dependently decreased anti-epileptic efficacy of CBZ but had no effect on plasma level of CBZ | May induce changes in neurotransmitter system causing sensitization effect | Gasior et al. 1996 [59] |
|
Food | Coca-Cola | Human | Healthy male volunteers (10) | Randomized two-way crossover design | PK parameters | Increased bioavailability of CBZ; no change in elimination | Enhanced dissolution of CBZ by its acidity | Malhotra et al. 2002 [60] |
|
DS | Folinic acid | Animal | Male Sprague-Dawley rats (4 in each group) | Randomized parallel controlled design | PK parameters | No effect on plasma or brain level of CBZ | N.D. |
Simth and Carl 1982 [61] |
|
Food | Grapefruit juice | Human | Patients with epilepsy (10) | Randomized crossover study | PK parameters | Increased bioavailability of CBZ | Inhibited CYP3A4-mediated intestinal and hepatic metabolism of CBZ | Garg et al. 1998 [62] |
|
Food | Honey | Animal | Angora grey rabbit (6 in each group) | Nonrandomized design | PK parameters | Decreased bioavailability of CBZ | Decreased metabolism of CBZ by inducing CYP enzymes |
Koumaravelou et al. 2002 [63] |
|
Food | Honey | Human | Healthy volunteers (10) | Randomized crossover study | PK parameters | Single dose of honey has no effect on pharmacokinetics of CBZ | N.D. | Malhotra et al. 2003 [64] |
|
Food | Honey | Human | Healthy male volunteers (12) | Open label crossover study | PK parameters | Multiple doses of honey have no effect on pharmacokinetics of CBZ | Flavanoids in honey may not affect human CYP3A4 activity | Thomas et al. 2007 [65] |
|
Food | Kinnow Juice | Human | Healthy male volunteers (9) | Randomized crossover study | PK parameters | Increased bioavailability of CBZ | Inhibited CYP3A activity | Garg et al. 1998 [66] |
|
DS | Melatonin | Animal | Female Swiss mice (12 in each group) | Randomized parallel design | PK and PD parameters |
Potentiated the anticonvulsant activity of CBZ but impair long-term memory but no effect on plasma and brain levels of CBZ | Enhanced GABAergic transmission in CNS | Borowicz et al. 1999 [67] |
|
DS | Melatonin | Human | Children with epilepsy (28) | Double-blind randomized control study | PK and PD parameters | Increased glutathione reductase (antioxidant) activity but no effect on plasma level of CBZ and its metabolite | Antagonized CBZ-triggered reactive oxygen species accumulation | Gupta et al. 2004 [68] |
|
DS | Melatonin | Animal | Male Swiss albino mice with maximal electroshock seizure model (7 in each group) | Randomized parallel design | PK and PD parameters | Synergistic anti-epileptic effect but no effect on plasma level of CBZ | N.D. | Gupta et al. 2004 [69] |
|
DS | Nicotinamide | Human | Children with epilepsy (2) | Case report | PK parameters | Increased plasma level of CBZ and decreased clearance of CBZ | N.D. | Said et al. 1989 [70] |
|
Food | Pomegranate juice | Animal | Male Wistar rats (5-6 in each group) | Randomized parallel design | PK parameters | Increased and AUC of CBZ; no change in elimination and AUC ratio of CBZ 10,11-epoxide to CBZ | Inhibited enteric but not hepatic CYP3A activity | Hidaka et al. 2005 [71] |
|
Food | Pomegranate juice | Ex vivo | Male Wistar rats (3 in each group) | In vitro everted and noneverted sac method | PK parameters | Decreased intestinal transport of CBZ | Induced enteric CYP3A4 | Adukondalu et al. 2010 [72] |
|
Food | Soybean | Animal | Albino Wistar rats (6 in each group) | Randomized parallel design | PK parameters | Decreased bioavailability of CBZ, increased plasma clearance and of CBZ | Decreased gastric emptying and enhanced elimination of CBZ |
Singh and Asad 2010 [73] |
|
Food | Star Fruit Juice | Animal | Male Wistar rats (6 in each group) | Randomized parallel design | PK parameters | Increased and AUC of CBZ; no change in elimination and AUC ratio of CBZ 10,11-epoxide to CBZ | Inhibited enteric but not hepatic CYP3A activity | Hidaka et al. 2006 [74] |
|